AJV-14034-05002
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 372 / TN
- Registered
- 2021-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-08
Dose 1 — Janssen/Johnson & Johnson
-
2021-12-21
Registered in v-safe
-
2021-12-21
Dose 2 — Pfizer-BioNTech
-
2021-12-21
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2021-12-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-12-23
-
2021-12-24
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion — Feeling: GoodFree text: Stuffy nose when I woke upMedDRA releases: 2024-11 · check-in free text available
- 2021-12-25
- 2021-12-27
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-01-18
- 2022-01-27
- 2022-02-01
- 2022-03-22
- 2022-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Janssen/Johnson & Johnson | No |
| 2 | 2021-12-21 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Stuffy nose when I woke up
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release